Abbott India Ltd.

View in App
22889.00 -196.85 ▼-0.9%

08 December 2023, 04:01:00 PM
Volume: 688

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.abbott.co.in
Market Cap 48,561.99 Cr.
Enterprise Value(EV) 46,610.44 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 508.93 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 44.91 Trailing Twelve Months Ending 2023-09
Industry PE 38.52 Trailing Twelve Months Ending 2023-09
Book Value / Share 1,463.07 Trailing Twelve Months Ending 2023-09
Price to Book Value 15.62 Calculated using Price: 22,853.45
Dividend Yield 1.42 Period Ending 2023-03
No. of Shares Subscribed 2.12 Cr. 21,249,302 Shares
FaceValue 10
About Abbott India Ltd.
The company is one of the leading multinational pharmaceutical companies in India and operates with owned manufacturing units and various independent contract/third party manufacturers based across the country. The company sells its products through independent distributors primarily within India.

Abbott India Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Abbott India Ltd. Performance

View details >>
1 Day
-0.85%
1 Week
-3.68%
1 Month
-3.64%
3 Month
-0.44%
6 Month
+4.65%
1 Year
+13.26%
2 Year
+22.19%
5 Year
+203.34%
10 Year
+1437.52%

Abbott India Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 26.54 23.93 21.54 26.35 24.66 27.09 27.89 29.95 32.07
Return on Capital Employed (%) 39.98 37.55 33.96 40.61 37.88 36.54 37.52 40.53 42.93
Return on Assets (%) 11.20 13.39 15.12 18.01 16.90 18.36 18.78 19.89 21.71

Abbott India Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 938 1,196 1,387 1,693 2,009 2,432 2,602 2,820 3,189 3,109
Non Curr. Liab. 432 29 35 41 62 210 190 184 144 140
Curr. Liab. 834 382 632 668 857 891 1,031 1,203 1,206 1,247
Minority Int.
Equity & Liab. 2,204 1,607 2,053 2,402 2,928 3,532 3,823 4,207 4,539 4,496
Non Curr. Assets 541 156 160 136 167 328 335 354 1,513 1,545
Curr. Assets 1,663 1,451 1,893 2,231 2,761 3,205 3,487 3,853 3,025 2,951
Misc. Exp. not W/O
Total Assets 2,204 1,607 2,053 2,402 2,928 3,532 3,823 4,207 4,539 4,496

Abbott India Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 2,289 2,615 2,903 3,299 3,679 4,093 4,310 4,913 5,349 5,643
Other Income 48 51 60 118 114 115 83 83 154 201
Total Income 2,338 2,666 2,963 3,417 3,793 4,208 4,393 4,997 5,503 5,844
Total Expenditure -1,978 -2,251 -2,508 -2,775 -3,075 -3,337 -3,391 -3,832 -4,143 -4,310
PBIDT 360 415 455 641 718 871 1,002 1,165 1,360 1,534
Interest -1 -3 -2 -4 -2 -9 -18 -19 -16 -14
Depreciation -15 -14 -16 -16 -17 -60 -58 -66 -70 -70
Taxation -115 -143 -160 -220 -249 -210 -235 -281 -324 -368
Exceptional Items
PAT 229 255 277 401 450 593 691 799 949 1,081
Adjusted EPS 108 120 130 189 212 279 325 376 447 509

Abbott India Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 155 215 249 307 153 499 626 727 948 893
Cash Fr. Inv. -144 -187 -77 -155 -215 -257 -401 -72 -396 -148
Cash Fr. Finan. -42 -58 -80 -90 -102 -143 -217 -582 -637 -639
Net Change -31 -30 91 62 -165 99 8 73 -86 107
Cash & Cash Eqvt 79 49 140 202 38 137 145 218 133 240

Abbott India Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 74.99 74.99 74.99 74.99 74.99 74.99 74.99 74.99 74.99
Public 25.01 25.01 25.01 25.01 25.01 25.01 25.01 25.01 25.01
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Abbott India Ltd. Announcements

View details >>
Fri, 10 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (LODR) Regulations 2015 please find enclosed the newspaper cuttings of the Unaudited Financial Results of the Company for the second quarter and half year ended September 30 2023 published in Business Standard (All Editions) and Loksatta today i.e. Friday November 10 2023.
Thu, 09 Nov 2023
Unaudited Financial Results Of The Company For The Second Quarter And Half Year Ended On September 30 2023
Unaudited Financial Results of the Company for the second quarter and half year ended on September 30 2023
Thu, 09 Nov 2023
Related Party Transactions For The Half Year Ended September 30 2023
Related Party Transactions for the half year ended September 30 2023

Abbott India Ltd. Technical Scans

View details >>
Fri, 08 Dec 2023
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Entering 52 Week Low Zone Close Entering 52 Week Low Zone
Close Below Last Week Low Close Below Last Week Low

Abbott India Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 296,437.84 1,235.50 -0.3%
Cipla Ltd. 98,444.27 1,218.85 -0.3%
Divi's Laboratories Ltd. 97,728.28 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. 96,135.30 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. 79,790.42 5,542.00 +1.5%
Mankind Pharma Ltd. 78,250.95 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. 69,508.23 2,056.00 -2.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.68 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-09 28.51 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-09 73.38 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.88 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.40 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 61.04 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.11 2,056.00 -2.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.96 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-09 3.97 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-09 7.71 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.77 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.27 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 9.28 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.36 2,056.00 -2.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,056.00 -2.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,056.00 -2.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,056.00 -2.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,056.00 -2.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,056.00 -2.2%

Abbott India Ltd. FAQ's

What is Abbott India share price?
Can I buy Abbott India shares now?
What is the Dividend Yield of Abbott India?
What is the Market Cap of Abbott India?
What are the key metrics to analyse Abbott India?
What is the 52 Week High and Low of Abbott India?
What is the trend of Abbott India share price?